Comparison Chart BioRestorative Therapies, Inc.
Stocks
BRTX
US0906556065
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3490 USD | -6.23% |
|
-9.00% | -70.14% |
| 06-25 | BioRestorative Therapies Completes Manufacturing for BRTX-100 Phase 2 Clinical Trial | CI |
| 06-16 | BioRestorative Therapies, Inc.'s Equity Buyback announced on August 12, 2025, has expired. | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIORESTORATIVE THERAPIES, INC. | Bio Therapeutic Drugs | -5.72% | -9.00% | -70.14% | -79.60% | -97.96% | 9.48M |
- Stock Market
- Stocks
- BRTX Stock
- Charts BioRestorative Therapies, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
















